China Summit Capital Joins $10M Series B Round In Impact Therapeutics
February 22, 2016 — 14:05 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese drug development start-up Impact Therapeutics has raised around US$10 million series B financing from new investors China Summit Capital, Guangzhou Yuexiu Industrial Investment Fund,... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals